Clinical application of second generation trombosite concentration

Basit Öğe Kaydı
dc.contributor.authorKoçyi?it, Ismail Doruk
dc.contributor.authorTunali, Mustafa
dc.contributor.authorÖzdemir, Hakan
dc.contributor.authorKartal, Yasemin
dc.contributor.authorSüer, Berkay Tolga
dc.date.accessioned2024-10-26T17:54:27Z
dc.date.available2024-10-26T17:54:27Z
dc.date.issued2012
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractThe therapeutic use of autologous platelet-rich fibrin constitutes a relatively new biotechnology that has been a breakthrough in the stimulation and acceleration of soft-tissue and bone healing. The efficiency of this process lies in the local and continuous delivery of a wide range of growth factors and proteins, mimicking the needs of the physiological wound healing and reparative tissue processes. Platelet-rich fibrin (PRF) belongs to a new generation of platelet concentrates, with simplified processing and without biochemical blood handling. This easy protocol allows the production of leukocyte and platelet-rich fibrin clots starting from autologous blood samples. PRF is used especially in clinical Periodontal and Oral and Maxillofacial Surgery applications. The significance of the PRF is gradually increasing.
dc.identifier.endpage287
dc.identifier.issn2146-2852
dc.identifier.issue3
dc.identifier.scopus2-s2.0-84866321473
dc.identifier.scopusqualityQ4
dc.identifier.startpage279
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27220
dc.identifier.volume15
dc.indekslendigikaynakScopus
dc.language.isotr
dc.relation.ispartofCumhuriyet Dental Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAutogenous fibrine; Growth hormone; Platelet
dc.titleClinical application of second generation trombosite concentration
dc.title.alternativeIkinci nesil trombosit konsantrasyonunun klinik uygulamalari
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu